ArticleOncoimmunology2023

ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer.

Guanpeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.